Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis

医学 内科学 荟萃分析 肿瘤科 优势比 人乳头瘤病毒 免疫组织化学 置信区间
作者
R.F. Shenker,Niema B. Razavian,Ralph B. D’Agostino,Yvonne M. Mowery,D.M. Brizel,Ryan T. Hughes
出处
期刊:Oral Oncology [Elsevier BV]
卷期号:148: 106644-106644 被引量:2
标识
DOI:10.1016/j.oraloncology.2023.106644
摘要

We aim to determine if there is a survival difference between patients with oropharyngeal squamous cell carcinoma (OPSCC) associated with human papillomavirus (HPV) 16 versus HPV-non16 subtypes.Databases were queried for full length, peer-reviewed, English language, articles published between 01/01/1980 and 06/08/2022. Studies reporting clinical outcomes of OPSCC associated with HPV16 and HPV-non16 subtypes with at least 10 patients were included. Primary outcome was the overall survival (OS) of patients with HPV16- versus HPV-non16-associated OPSCC. Secondary outcomes were recurrence-free survival (RFS) and pooled rate of p16 positivity by immunohistochemistry (IHC).A total of 9 studies met inclusion criteria and included 1,310 patients with HPV16 and 219 with HPV-non16 subtypes of OPSCC. The prevalence of HPV-non16 was 14.3 %. The pooled 5-year OS rates for patients with HPV16 and HPV-non16 were 83.4 %(95 % CI 77.8-89.0 %) and 69.3 %(95 % CI 58.5-80.1 %), respectively. OS at 5 years was significantly worse for HPV-non16 subtype, compared to HPV16 (log odds ratio [OR] -0.54, p = 0.008). There was a trend towards worse 5-year RFS with HPV-non16 compared to HPV16 (log OR -0.55, p = 0.063). Patients with HPV-non16 disease were less likely to be p16 positive by IHC (log OR -0.91, p = 0.02).Patients with HPV-non16OPSCC may experience worse OS and were less likely to be p16 positive compared to patients with HPV16 disease. While future prospective validation is warranted, routine assessment of both p16 IHC and HPV subtype could be considered prior to pursuing treatment de-escalation for HPV-associated OPSCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cyndi完成签到,获得积分0
3秒前
4秒前
贰鸟应助七月流火采纳,获得10
5秒前
yulia完成签到 ,获得积分10
6秒前
佳期如梦完成签到 ,获得积分10
6秒前
7秒前
阿Q完成签到,获得积分10
8秒前
9秒前
彬琪发布了新的文献求助10
10秒前
10秒前
11秒前
11秒前
雨木目完成签到,获得积分10
12秒前
小鱼完成签到,获得积分10
12秒前
chenkaixin发布了新的文献求助10
12秒前
梦XING完成签到 ,获得积分10
13秒前
eternity136发布了新的文献求助10
13秒前
vv完成签到,获得积分10
14秒前
14秒前
哈哈哈哈发布了新的文献求助20
14秒前
KANG完成签到,获得积分10
15秒前
义气黄焖排骨完成签到,获得积分10
15秒前
16秒前
如梦如画发布了新的文献求助10
16秒前
Hannes应助15902933324sjc采纳,获得10
17秒前
17秒前
17秒前
梓默完成签到 ,获得积分10
17秒前
我是老大应助Japan采纳,获得10
18秒前
彬琪完成签到,获得积分10
18秒前
红尘踏歌完成签到,获得积分10
18秒前
不忘初心发布了新的文献求助10
19秒前
18746005898完成签到 ,获得积分10
19秒前
chenkaixin完成签到,获得积分10
20秒前
WangZhen完成签到,获得积分20
21秒前
乔木木完成签到,获得积分10
21秒前
一路畅通accept完成签到,获得积分10
21秒前
潇湘学术完成签到,获得积分10
21秒前
烂漫的如冬完成签到,获得积分10
22秒前
koi发布了新的文献求助10
22秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038619
求助须知:如何正确求助?哪些是违规求助? 3576294
关于积分的说明 11375058
捐赠科研通 3306084
什么是DOI,文献DOI怎么找? 1819374
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815066